Chronic Low Back Pain
Abuse-deterrent extended-release oxycodone (Xtampza® ER; Collegium Pharmaceutical) provided adequate pain relief for patients with chronic low back pain who were previously receiving immediate-release oxycodone.
Physiotherapy combined with routine or stabilization exercises is effective for reducing pain and improving muscle dimensions in patients with nonspecific chronic low back pain.
Gabapentinoid use presents significant risk for adverse events and provides few benefits for patients with chronic low back pain.
Early pain response to duloxetine predicts better outcomes in patients with chronic low back pain.
Radiofrequency denervation may be ineffective in alleviating chronic low back pain.
Radiofrequency denervation improved chronic low back pain arising from the facet joints.
Long-term, clinically important improvement in chronic low back pain can be achieved with lumbar total disc replacement and multidisciplinary rehabilitation in patients whose low back pain does not respond to conservative therapy.
Tanezumab is a NGF inhibitor and is a first-in-class agent to receive Fast Track approval.
A single glucocorticoid intradiscal injection provided relief from low back pain at 1, but not 12 months in patients with active discopathy.
Nektar Therapeutics announced positive results from the SUMMIT-07 Phase 3 study of NKTR-181 for the treatment of moderate-to-severe chronic pain.
Meta-analysis indicates short-term NSAID use is generally safe and can relieve pain, but lacks clinically important benefits.
For patients with chronic lumbar back pain, ablation of the basivertebral nerve improves self-reported outcome.
Lumbopelvic stabilization training provides therapeutic effects on chronic nonspecific low back pain conditions.
"Our study shows that clinically significant placebo effects can be produced even when patients are told that they are being given placebos."
Though these initial findings seem promising, the utility of the device may be limited to a small number of patients, according to Steven P. Cohen, MD.
Meta-analysis shows muscle relaxants are effective in reducing acute but not chronic low back pain.
Clinical Pain Advisor Articles
- Virtual Reality for Pain Relief: Understanding the Underlying Mechanisms
- Vibrating Gloves Significantly Reduce Osteoarthritis-Related Hand Pain
- Neuroimaging for Chronic Pain: IASP Consensus Statement
- Neuroinflammation in Neuropathic Pain Indicated by Elevated Levels of Proinflammatory Chemokines in CSF
- Hypertension in Chronic Pain: Risk Factors
- Liposomal Bupivacaine Effective for Shoulder Arthroplasty-Related Pain
- Reducing the P-Value for Statistical Significance to Improve the Quality of Research?
- FDA's Strategies for Managing Patients Taking CNS Depressants and Opioids
- Electrotherapy, Acupuncture May Decrease Pain Following Total Knee Arthroplasty
- Low-Dose Oromucosal Ibuprofen Effective for Relieving Sore Throat
- Survey Finds Teens Divided on Beliefs and Attitudes of Prescription Drug Abuse
- HIV-Positive Patients Experience Frequent Headaches
- Low-Dose Perineural Dexamethasone Prolongs Effects of Brachial Plexus Nerve Block
- Business Savvy Tips for Buying a Practice
- Diphenhydramine Decreases Pain During Colonoscopy for Chronic Opioid Users